Abstract:Neurodegenerative diseases are becoming prevalent as the population ages. Geniposide could inhibit oxidative stress, reduce apoptosis, protect neuron, and has been used for therapy of the neurodegenerative diseases. The bioavailability of geniposide by nasal route is greater than that by oral administration. However, mucociliary clearance is a rate-limiting factor for nasal route administration. The objective of this study was to develop and evaluate a mucoadhesive, thermoreversible in situ nasal gel of geniposide. The poloxamers (P407, P188) and the hydroxypropyl methylcellulose were used as thermoreversible and mucoadhesive polymers, respectively. Borneol was used as a permeation enhancer. The hydrogel was prepared with the cold method and optimized by the response surface methodology-central composite design. Gelation temperature, pH, clarity, gel strength, mucoadhesive strength, in vitro and ex vivo release kinetics of formulations were evaluated. The optimized amounts of poloxamer407 (P407), poloxamer188 (P188) and hydroxypropyl methylcellulose were determined to be 19.4-20.5%, 1.1-4.0% and 0.3-0.6% respectively. The second-order polynomial equation in terms of actual factors indicated a satisfactory correlation between the independent variables and the response (R2 = 0.9760). An ANOVA of the empirical second-order polynomial model indicated the model was significant (P<0.01). P407, P188, P407×P188, P4072 and P1882 were significant model terms. The effects of P407 on gelation temperature were greater than those of other independent variables. The pH values of all the formulations were found to be within 6.3-6.5 which was in the nasal physiological pH range 4.5-6.5. The drug content, gel strength, mucoadhesive strength of the optimized formulations were 97-101%, 25-50 sec and 4000-6000 dyn/cm2 respectively. The in vitro release kinetics of cumulative release of geniposide was fitted to the zero-order model. The ex vivo cumulative release kinetics of geniposide was fitted to the Weibull model. This study concludes that the release of geniposide is controlled by gel corrosion, and that the permeation of geniposide is time-dependent. The more residence time, mucoadhesive, thermoreversible in situ nasal gel of geniposide for neurodegenerative diseases is of compliance and potential application.

Study on pharmacokinetics of geniposide in mice administrated by Xingnaojing microemulsion and mPEG2000-PLA modified Xingnaojing microemulsion

Study on brain drug concentration of geniposide in mice after iv injected with Xingnaojing Injection and its pharmacokinetics

Comparative Study on Rat in Situ Nasal Absorption of Geniposide of Xingnaojing Nasal Drop and Xingnaojing Microemulsion

Pharmacokinetics of Ginsenosides Rg1, Re and Notoginsenoside R1 in Rats by an in vivo Microdialysis Coupled with Liquid Chromatography/Mass Spectrometry

Transdermal Behavior of Geniposide in Shangyi Aerosol in vivo and in vitro

Enhancing effect of natural borneol on the absorption of geniposide in rat via intranasal administration

Preparation of Mpeg2000-Pla-modified Xingnaojing Microemulsion and Evaluation in Mucosal Irritation.

Pharmacokinetics and Tissue Distribution Study of Gambogic Acid and Gambogic Acid Nanosuspension in Mice by UHPLC-MS/MS

A mucoadhesive, thermoreversible in situ nasal gel of geniposide for neurodegenerative diseases

Pharmacokinetics of N-methylcantharidimide after Intragastral and Intravenous Administration

Preparation of Nasal Ethosome Spray of Geniposide and Its Nasal Mucosa Permeability in Vitro

In vivo pharmacokinetics and distribution of nimodipine microemulsion injection in mice

[Study on Pharmacokinetics of Borneol in Rats Injected with Novel-Xingnaojing by GC-FID].

Study on the Characteristics of Pharmacokinetics of Different Doses of Gastrodin in Mice

HPLC method for the determination and pharmacokinetic studies on geniposide in rat serum after oral administration of traditional Chinese medicinal preparation Yin-Zhi-Ku decoction.

Pharmacokinetics And Tissue Distribution Of Gentiopicroside In Mice After Oral And Injection Of Vein Administration

Pharmacokinetics and Tissue Distribution of Gentiopicroside Following Oral and Intravenous Administration in Mice

Evaluation of intestinal absorption of ginsenoside Rg1 incorporated in microemulison using parallel artificial membrane permeability assay.

Influence of Glycerol/Dimethylsulfoxide Homogeneous Solution on PNS Bioavailability in rats

GC-MS/MS Method for the Determination and Pharmacokinetic Analysis of Borneol and Muscone in Rat after the Intravenous Administration of Xingnaojing Injection

The Brain Targeting Efficiency Following Nasally Applied Mpeg-Pla Nanoparticles In Rats